Report cover image

2026 Global: Hospital Acquired Infection Control Market-Competitive Review (2032) report

Publisher PerryHope Partners
Published Apr 15, 2025
Length 32 Pages
SKU # PHP21162638

Description

The 2026 Global: Hospital Acquired Infection Control Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.

Major players shaping hospital-acquired infection control include 3M, BD, STERIS, Getinge AB, and Ecolab, each bringing comprehensive portfolios of disinfection, sterilization, and infection-prevention services. 3M operates from St. Paul, United States, with broad offerings in surface disinfectants, sterilization indicators, and safety products. BD, headquartered in Franklin Lakes, United States, supplies diagnostic instruments, devices, and related infection-control materials. STERIS, based in Mentor, United States, provides sterilization systems, cleaning and disinfection services, and operating room solutions. Getinge AB, headquartered in Gothenburg, Sweden, manufactures sterilization equipment, disease-control systems, and integrated hospital infrastructure. Ecolab, anchored in St. Paul, United States, delivers cleaning and disinfection programs, pharmacare-grade disinfectants, and data-driven sanitation management. Together these firms anchor the HAI control market, combining product breadth, global service networks, and compliance expertise to support hospitals and health systems worldwide. These leaders shape policy adoption, drive standardization, and enable rapid response to emerging threats across regions and beyond, globally.

Mölnlycke Health Care, based in Gothenburg, Sweden, supplies aseptic operating room products, advanced wound care, and infection-prevention textiles used in routine care and procedures. Cardinal Health, headquartered in Dublin, Ohio, United States, integrates medical supply distribution with sterilization services, inventory management, and clinical optimization to reduce hospital-acquired risks. Medline Industries, Northfield, United States, offers a broad portfolio of disposable and reusable surgical products, disinfectants, and educational programs to drive standardized practices. Drägerwerk AG & Co. KGaA, headquartered in Lübeck, Germany, contributes respiratory protection, patient monitoring, and safety technology that support infection control and staff protection. Owens & Minor, based in Richmond, United States, provides procurement, supply chain services, and PPE distribution essential for day-to-day infection-prevention activities across facilities. Together these firms extend advanced materials, analytics, and service platforms that hospitals rely on to standardize protocols, track outcomes, and accelerate incident response during outbreaks while maintaining patient safety and workforce resilience globally.

Across the Hospital Acquired Infection Control Market, the ten firms cited here contribute complementary capabilities spanning disinfectants, PPE, sterilization technology, data analytics, and supply chain services. 3M advances surface protection and rapid diagnostics; BD advances needles, instruments, and point-of-care testing; STERIS integrates sterilization devices with cleaning programs; Getinge delivers comprehensive hospital infrastructure and sterilization ecosystems; Ecolab supports facility-wide sanitation management. Mölnlycke applies barrier products and procedure packs to reduce contamination during procedures; Cardinal Health links product availability with compliance reporting; Medline supplies broad disposable and chemical portfolios along with training resources; Dräger supports protective equipment, air quality, and patient monitoring; Owens & Minor ensures efficient PPE distribution and sourcing. Overall, these companies shape quality standards, drive cost-efficient infection-control programs, and enable hospitals to protect patients, protect staff, and optimize operational readiness in the face of evolving pathogens. Continued investment in research, standards, and collaboration will sustain progress for patient safety.

Table of Contents

32 Pages
1.0 Scope of Report and Methodology
2.0 Market SWOT Analysis and Players
2.1 Market Definition
2.2 Market Segments
2.3 Market Strengths
2.4 Market Weaknesses
2.5 Market Threats
2.6 Market Opportunities
2.7 Major Players
3.0 Competitive Analysis
3.1 Market Player 1
3.2 Market Player 2
3.3 Market Player 3
3.4 Market Player 4
3.5 Market Player 5
3.6 Market Player 6
3.7 Market Player 7
3.8 Market Player 8
3.9 Market Player 9
3.10 Market Player 10
4.0 Comparative Business Strategies
4.1 Comparative Business Strategies of Player 1 and 2
4.2 Comparative Business Strategies of Player 1 and 3
4.3 Comparative Business Strategies of Player 1 and 4
4.4 Comparative Business Strategies of Player 2 and 3
4.5 Comparative Business Strategies of Player 2 and 4
4.6 Comparative Business Strategies of Player 3 and 4
5.0 Appendix

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.